RBFC
CVS icon

Roman Butler Fullerton & Co’s CVS Health CVS Stock Holding History

Roman Butler Fullerton & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,535
Closed -$425K – 239
2024
Q3 		$425K Sell
6,535
-307
-4% -$17.9K 0.13% 165
2024
Q2 		$394K Sell
6,842
-2,744
-29% -$172K 0.13% 161
2024
Q1 		$667K Sell
9,586
-2,227
-19% -$170K 0.25% 96
2023
Q4 		$862K Sell
11,813
-1,663
-12% -$118K 0.34% 79
2023
Q3 		$964K Sell
13,476
-427
-3% -$30.3K 0.46% 64
2023
Q2 		$1.03M Buy
13,903
+2,150
+18% +$153K 0.47% 65
2023
Q1 		$856K Sell
11,753
-236
-2% -$19.8K 0.43% 74
2022
Q4 		$1.07M Sell
11,989
-133
-1% -$12.8K 0.55% 57
2022
Q3 		$1.07M Sell
12,122
-62
-0.5% -$6.14K 0.68% 42
2022
Q2 		$1.16M Buy
12,184
+137
+1% +$13.4K 0.65% 42
2022
Q1 		$1.22M Sell
12,047
-2,563
-18% -$269K 0.56% 51
2021
Q4 		$1.51M Sell
14,610
-100
-0.7% -$9.24K 0.67% 45
2021
Q3 		$1.24M Sell
14,710
-46
-0.3% -$3.85K 0.58% 57
2021
Q2 		$1.23M Buy
14,756
+58
+0.4% +$4.75K 0.6% 52
2021
Q1 		$1.11M Sell
14,698
-52
-0.4% -$3.79K 0.56% 59
2020
Q4 		$1.01M Buy
14,750
+1,514
+11% +$98.5K 0.59% 57
2020
Q3 		$773K Sell
13,236
-1,974
-13% -$123K 0.51% 65
2020
Q2 		$988K Sell
15,210
-1,457
-9% -$91.7K 0.7% 49
2020
Q1 		$989K Sell
16,667
-676
-4% -$45.1K 0.87% 34
2019
Q4 		$1.29M Sell
17,343
-284
-2% -$19.9K 0.85% 33
2019
Q3 		$1.11M Buy
17,627
+6
+0% +$356 0.77% 36
2019
Q2 		$960K Buy
17,621
+4,091
+30% +$220K 0.65% 47
2019
Q1 		$730K Sell
13,530
-182
-1% -$11.2K 0.51% 61
2018
Q4 		$899K Buy
+13,712
New +$1.02M 0.76% 41

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Roman Butler Fullerton & Co's CVS Position: Q4 2024 in Review

Roman Butler Fullerton & Co sold out of CVS Health (CVS) in Q4 2024, closing a stake of 6,535 shares — an estimated $425K sold.

Roman Butler Fullerton & Co first reported a position in CVS in Q4 2018 and held it in 24 quarters. The position peaked at $1.51M in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Roman Butler Fullerton & Co reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Roman Butler Fullerton & Co sold 6,535 CVS Health shares in Q4 2024, an estimated $425K.
  • Roman Butler Fullerton & Co first reported a position in CVS Health in Q4 2018 and held it in 24 quarters.
  • Roman Butler Fullerton & Co's CVS Health position peaked at $1.51M in Q4 2021.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Roman Butler Fullerton & Co's 13F filing for Q4 2024, filed 30 Jan 2025.